ACCEPTED MANUSCRIPT
6
Tetrahedron
1420, 1200, 1140; 1H NMR (500 MHz, CDCl3): δH = 8.00 (1 H,
4. (a) Guiry, P. J.; Saunders, C. P. Adv. Synth. Catal. 2004, 346, 497.
(b) McCarthy, M.; Guiry, P. J. Tetrahedron 2001, 57, 3809.
d, J=9.0 Hz, ArH), 7.95 (1 H, d, J = 8.1 Hz, ArH), 7.70 (1 H, dd,
J=8.4, 1.0 Hz, ArH), 7.56 (1 H, ddd, J = 8.2, 6.8, 1.2 Hz, ArH),
7.51 - 7.46 (2 H, m, 2xArH), 7.38 (1 H, td, J=7.5, 1.3 Hz, ArH),
7.31 (1 H, dd, J=7.5, 1.2 Hz, ArH), 7.09 (1 H, td, J=7.5, 1.2 Hz,
ArH), 6.75 (1 H, dd, J=7.6, 1.2 Hz, ArH), 4.19 - 4.05 (2 H, m,
NCHAHBCH2Ar), 3.09 - 2.93 (2 H, m, NCH2CH2Ar) ppm; 13C
{1H} NMR (125 MHz, CDCl3): δC =162.7 (C=N), 144.6 (ArC),
137.3(ArC), 132.6 (ArC), 131.6 (ArC), 131.1 (ArC), 129.7
(ArC), 129.3 (ArC), 128.4 (ArC), 128.0 (ArC), 127.8 (ArC),
127.3 (ArC), 127.3 (ArC), 127.1 (ArC), 126.3 (ArC), 119.8
(ArC), 119.4 (ArC), 117.3 (ArCSO2CF3), 48.1 (NCH2CH2Ar),
25.7 (NCH2CH2Ar); HRMS (ESI+) m/z calcd for
C20H14F3NNaO3S [M+Na+]: 428.0539, found: 428.0544. HPLC:
Chiralpak® AD-H, n-Hex:IPA = 80:20, T = 25 oC; flow = 1
mL/min, λ = 254 nm, tR,A = 4.8 min, tR,B = 8.2 min.
5. (a) Pfaltz, A. Angew. Chem. Int. Ed. Engl. 1993, 32, 566. (b) Valk,
J. M.; Whitlock, G. A.; Layzell, T. P.; Brown, J. M. Tetrahedron
Asymm. 1995, 6, 2593. (c) Doucet, H.; Fernandez, E.; Layzell, T.
P.; Brown, J. M. Chem. Eur. J. 1999, 5, 1320. (d) Fernández, E.;
Guiry, P. J.; Connole, K. P. T; Brown, J. M. J. Org. Chem. 2014,
79, 5391.
6. Pedersen, J. R. Acta Chem. Scand. 1972, 26, 929.
7. Cortright, S. B.; Yoder, R.A.; Johnston, J. N. Heterocycles 2004,
62, 223.
8. Baker, R.W.; Rea, S.O.; Sargent, M.V.; Schenkelaars, E.M.C.;
Skelon, B. W.; White, A. H. Tetrahedron Asymm 1994, 5, 45.
9. Feng, J.; Dastgir, S.; Li, C. Tetrahedron Lett. 2008, 49, 668.
10. Christopher, J. A.; Atkinson, F. L.; Bax, B. D.; Brown, M. J. B.;
Champigny, A. C.; Chuang, T. T.; Jones, E. J.; Mosley, J. E.;
Musgrave, J. R. Bioorg. Med. Chem. Lett. 2009, 19, 2230.
11. Thaler, T.; Geittner, F.; Knochel, P. Synlett 2007, 2655
12. (a) Clayden, J.; Fletcher, S. P.; McDouall, J. J. W.; Rowbottom, S.
J. M. J. Am. Chem. Soc. 2009, 131, 5331; (b) Bhat, V.; Wang, S.;
Stoltz, B. M.; Virgil, S. C. J. Am. Chem. Soc. 2013, 135, 16829.
13. (a) Clayden, J.; Senior, J.; Helliwell, M. Angew. Chem. Int. Ed.
2009, 48, 6270; (b) Clayden, J. Angew. Chemie. Int. Ed. Engl.
1997, 36, 949; (c) Kumarasamy, E.; Raghunathan, R.; Jockush, S.;
Ugrinov, A.; Sivaguru, J., J. Am. Chem. Soc. 2014, 136, 8729; (d)
Bai, X-F.; Song, T.; Xu, Z.; Xia, C-G; Huang, W-S.; Xu, L-W,
Angew. Chem. Int. Ed. 2015, 54, 5255; (e) Kumarasamy, E.;
Raghunathan, R.; Sibi, M. P.; Sivaguru, J., Chem. Rev. 2015, 115,
11239; (f) Brandes, S.; Niess, B.; Bella, M.; Prieto, A.; Overgaard,
J.; Jørgensen, K. A. Chem. Eur. J. 2006, 12, 6039; (g) Kitagawa,
O.; Kurihara, D.; Tanabe, H.; Shibuya, T.; Taguchi, T,
Tetrahedron Lett. 2008, 49, 471; (h) Clayden, J. P.; Lai, L. W;
Angew. Chem. Int. Ed. 1999, 38, 2556; (i) Clayden, J.; Helliwell,
M.; Pink, J. H.; Westlund, N. J. Am. Chem. Soc. 2001, 123, 12449;
(j) Betson, M. S.; Clayden, J.; Lam, H. K.; Helliwell, M. Angew.
Chemie Int. Ed. 2005, 44, 1241; (k) Clayden, J.; Lund, A.;
Vallverdu, L.; Helliwell, M. Nature (London) 2004, 431, 966; (l)
Yuan, B.; Page, A.; Worrall, C. P.; Escalettes, F.; Willies, S. C.;
McDouall, J. J. W.; Turner, N. J.; Clayden, J. Angew. Chemie. Int.
Ed. 2010, 49, 7010.
4.4. (1-(3,4-Dihydroisoquinolin-1-yl)naphthalen-2-
yl)diphenylphosphine oxide (4i)
Compound 4i was prepared according to the method of Mikami
et al.17 Dimethylsulfoxide (8 mL) and diisopropylethylamine
(1.29 mL, 7.4 mmol) were added to a mixture of 1-aryl-3,4-
dihydroisoquinoline 4h (600 mg, 1.48 mmol), diphenylphosphine
oxide (617 mg, 2.96 mmol), palladium diacetate (33 mg, 0.15
mmol, 10 mol%), and 1,3-bis(diphenylphosphino)propane (dppp;
94 mg, 0.22 mmol, 15 mol%), and the mixture was heated with
stirring at 100 ºC for 22 h. After cooling to room temperature, the
reaction mixture was diluted with EtOAc, washed with water,
dried over MgSO4, and concentrated again under reduced
pressure. The crude product was purified by flash column
chromatography (EtOAc:MeOH 95:5) to afford the title
compound as a yellow solid (0.508 g, 75%); 4i: Rf (95:5
EtOAc:MeOH ) 0.6; m.p. 97-98 ºC; IR (film, cm-1): νmax = 1629
1
(C=N), 1196; H NMR (400 MHz, CDCl3): δH = 7.88 (2 H, dd,
14. (a) Bischler, A.; Napieralski, B. Ber. 1893, 26, 1903 (b)
Movassaghi, M.; Hill, M. D. Org. Lett. 2008, 10, 3485.
15. Schröder, N.; Wencel-Delord, J.; Glorius, F. J. Am. Chem. Soc.
2012, 134, 8298.
16. Sun, X.; Shan, G.; Sun, Y.; Rao, Y. Angew. Chem. Int. Ed. 2013,
52, 1-6.
J=8.6, 1.3 Hz, 2xArH), 7.71 (1 H, d, J=8.8 Hz, ArH), 7.65 - 7.50
(6 H, m, 6xArH), 7.50 - 7.31 (7 H, m, 7xArH), 7.23 (1 H, td,
J=7.3, 1.0 Hz, ArH), 7.17 (1 H, dd, J=7.3, 0.5 Hz, ArH), 6.88 (1
H, td, J=7.4, 1.3 Hz, ArH), 6.59 (1 H, d, J=7.1 Hz,ArH), 3.81 (2
H, m, NCH2CH2Ar), 3.01 (1 H, dt, J=16.0, 8.0 Hz,
NCH2CHXCHYAr), 2.81 ppm (1 H, dt, J=16.0, 7.0 Hz,
17. Ding, K.; Wang, Y.; Yun, H.; Liu, J.; Wu, Y.; Terada, M.; Okubo,
Y.; Mikami, K. Chem. Eur. J. 1999, 5, 1734.
18. Adept Scientific, gNMR, version 5, Letchworth Garden City,
Herts, SG6 1ZA. UK.
19. Dynamic Stereochemistry of Chiral Compounds, Wolf, C. 2008
(pub. Royal Society of Chemistry); Wolf, C. Chem. Soc. Rev.
2005, 34, 595.
20. (a) Trapp, O.; Schurig, V. J. Chromatogr. A 2001, 911, 167; (b) O.
Trapp, V. Schurig, Chirality 2002, 14, 465; (c) Trapp, O. Anal.
Chem. 2006, 78, 189.
21. (a) Clayden, J.; Fletcher, S. P.; Senior, J.; Worrall, C. P.
Tetrahedron: Asymm 2010, 21, 1355; (b) Betson, M. S.; Clayden,
J.; Worrall, C. P.; Peace, S. Angew. Chem. Int. Ed. 2006, 45, 5803;
(c) Clayden, J., Worrall, C. P., Moran, W. J., Helliwell, M. Angew.
Chemie Int Ed. 2008, 47, 3234.
NCH2CHXCHYAr); 13C {1H} NMR (100 MHz, CDCl3): δC
=
166.3 (ArC=N, d, J(13C,31P) = 4.0 Hz), 143.3 (ArC, d, J(13C,31P))
= 8.0 Hz), 136.8, 134.6, 134.6, 134.2, 133.5, 132.2, 132.1, 132.0,
132.0, 131.9, 131.4, 131.4, 130.8, 130.4, 128.6, 128.2, 128.2,
128.1, 128.1, 128.0, 128.0, 127.9, 127.7, 127.5, 127.3, 127.2,
127.1, 126.7, 126.3, 47.5 (NCH2CH2Ar), 25.4 (NCH2CH2Ar)
ppm; 31P {1H} NMR (162 MHz, CDCl3): δP = 29.6 ppm. HRMS
(ESI+) m/z calcd for C31H24ONNaP [M+Na+]: 480.1488, found:
480.1475. HPLC: (R,R)-Whelk-O1, n-Hex:IPA = 60:40, T = 50
oC; flow = 1 mL/min, λ = 254 nm, tR,A = 6.8 min, tR,B = 10.2 min.
22. Oki, M. Top. Stereochem. 1983, 14, 1.
23. Eliel, E. L.; Wilen, S. H.; Mander, L. N. Stereochemistry of
Organic Compounds 1994 (pub Wiley)
Acknowledgments
We are grateful to the EU Erasmus programme, the BBSRC,
and Johnson Matthey Catalysts for support of this work.
24. (a) Abu-Gnim, C.; Amer, I. Chem. Soc., Chem. Commun.,
1994, 115; (b) Tolis, E. I.; Vallianatou, K. A.; Andreadaki, F. J.;
Kostas, I. D. Appl. Organometal. Chem. 2006, 20, 335.
25. (a) Janin, Y. L.; Roulland, E.; Beurdeley-Thomas, A.; Decaudin,
D.; Monneret, C.; Poupon, M. F. J. Chem. Soc., Perkin Trans. 1
2002, 529; (b) Funder, E. D.; Trads, J. B.; Gothelf, K. V. Org.
Biomol. Chem 2015, 185; (c) Gualtierotti, J-B.; Schumacher, X.;
Fontaine, P.; Masson, G.; Wang, Q.; Zhu, J. Chem. Eur. J. 2012,
14812; (d) Dumas, A. M.; Molander, G. A.; Bode, J. W. Angew.
Chem. Int. Ed. 2012, 5683.
26. (a) Yang, J.; Hua, W.-Y.; Wang, F.-X.; Wang, Z.-Y.; Wang, X.
Bioorg. Med. Chem. 2004, 12, 6547; (b) Vedejs, E.; Trapencieris,
P.; Suna, E., J. Org. Chem. 1999, 64, 6724; (c) Wu, Z.; Perez, M.;
Scalone, M.; Ayad, T.; Ratovelomanana-Vidal, V. Angew. Chem.
Int. Ed. 2013, 52, 4925.
References and notes
1. (a) Bringmann, G.; Mortimer, A. J. P.; Keller, P. A.; Gresser, M.
J.; Garner, J.; Breuning, M. Angew. Chem. Int. Ed. 2005, 44, 5384;
(b) Staniland, S.; Yuan, B.; Giménez-Agulló, N.; Marcelli, T.;
Willies, S.; Grainger, D. M.; Turner, N. J.; Clayden, J. Chem. Eur.
J. 2014, 20, 13084 and references therein.
2. Alkorta, I.; Elguero, J.; Roussel, C.; Vanthuyne, N.; Piras, P. Adv.
Heterocycl. Chem. 2012, 105, 1.
3. Suau, R.; Rico, R.; Lopez-Romero, J.M.; Najera, F.; Cuevas, A.
Phytochemistry 1998, 49, 2545